GlassScriptPhysician profile
Ram B Agrawal
NPI 1982708467
$2,949.87
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $939.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $459.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $327.07 | 2019-2020 | |
| Lilly USA, LLC | $269.73 | 2019-2020 | |
| Novo Nordisk INC | $260.59 | 2019-2020 | |
| Glaxosmithkline, LLC. | $213.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $173.90 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.83 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $108.29 | 2019-2020 | |
| Mannkind Corporation | $107.54 | 2019 | |
| Amarin Pharma, INC. | $96.59 | 2019-2020 | |
| Abbott Laboratories | $94.52 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.71 | 2019-2020 | |
| Pfizer INC. | $72.17 | 2019-2020 | |
| Amgen INC. | $64.94 | 2019 | |
| Abbvie INC. | $59.94 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $59.92 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $50.37 | 2020 | |
| Esperion Therapeutics, INC. | $43.56 | 2020 | |
| Ibsa Pharma INC. | $41.46 | 2019-2020 | |
| Antares Pharma, INC. | $34.20 | 2019 | |
| Eisai INC. | $24.99 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $24.49 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $23.04 | 2019 | |
| Sanofi Pasteur INC. | $20.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.64 | 2019 | |
| Seqirus USA INC | $18.84 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.75 | 2020 | |
| Allergan, INC. | $13.62 | 2019 | |
| Becton, Dickinson and Company | $13.38 | 2020 | |
| Medtronic Minimed, INC. | $12.68 | 2019 | |
| Dexcom, INC. | $12.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ram Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.